Loading transcript...
Click for full transcript
Chapters & Sections (184)
▼
00:00
Host Introduction to New York Debate Event
00:32
Choosing Dan Wilson as Scientific Counterpart
01:03
Antivaxer Steve Kersh and Pierre Corey Partnership
01:34
Debate Topic Overview and Production Negotiations
02:06
Disengagement of Pierre Corey During Debate
02:38
Antivaxer Influence on Social Media and Public Health
03:10
Debate Highlights Preview and Sponsor Interjection
03:41
Fact‑Checking Approach and Dan Wilson’s Role
07:18
Autism Genetic Nature vs Vaccine Claim
08:00
Debate Framing and Speaker Introduction
09:23
Profiteering Through Ivermectin and Personalized Health
10:46
Speaker's Medical Background and Credibility
11:29
Money Motive Behind Anti‑vax Positions
12:33
Intelligence Critique of Anti‑vaxxers
13:04
Personal Vaccine Experience and Anecdotal Claims
13:34
Data Review and Article Publication
14:36
Critique of Self‑Reporting Databases and Conclusion
15:07
Accusation of Wrongful Statements and Lack of Evidence
15:37
Demand for Data Transparency in Public Health
16:07
Introduction of Vaccine Schedule and Autism Connection
16:38
Vaccine Schedule Discussion and Anti-Vax Positioning
17:09
Ingredient Misconceptions: Mercury, Thyrostatin, and Preservatives
22:49
Aluminum Levels Allegedly Off the Charts in a Child’s Brain
23:21
Reference to Chrisley’s Long‑Term Research and Autism Claim
23:52
Questioning the Validity of the Exley Paper’s Data
24:22
Highlighting Lack of Direct Examination of Numbers
24:54
Presentation of Contradictory Peer‑Reviewed Findings on Aluminum
25:56
Emphasis on Technical Replicates and Data Variability
26:59
Reiteration of Lack of Causal Mechanism Linking Aluminum to Autism
27:50
Comparison with a Multicenter Study Showing No Increase in Autism Brains
28:43
Final Critique of Data Reliability and Call for More Robust Evidence
30:07
Congressional Committee Findings on Agent Orange and Gulf War Toxins
30:37
Discussion of Anthrax Vaccine Ingredients and Veteran Health Claims
31:09
Critique of Mechanism‑Based Arguments in Toxicology
31:39
Analysis of International Scientific Collaboration and Bias
32:10
Aluminum as a Contested Vaccine Adjuvant
32:41
Debunking Anecdotal Claims Linking Vaccines to Autism
33:13
Overview of the Versat Study and Its Alleged Findings
34:16
Secret Meeting on Thyrosol and Vaccine Messaging
34:46
Misrepresentation of Thyrosol’s Presence in Vaccines
35:17
Epidemiological Flaws in the Versat Study Design
36:09
Control of Confounding Factors in Vaccine‑Autism Research
37:55
Verstatron’s Number Manipulation Claims
38:20
Repetition of Parrot‑Like Stories by Steve
38:25
Email Evidence About Signal Persistence
38:56
Final Thoughts on Diagnostic Criteria
39:57
Historical DSM Additions for Autism Spectrum Disorder
40:28
Impact of Diagnostic Changes on Statistics
41:02
Genetic Evidence for Autism
41:35
Genome‑Wide Association and Twin Studies
42:07
Expanded Diagnostic Criteria Over the Past Decades
43:08
Rapid Onset Claims and Vaccine Timing
44:43
CDC Study Suppression Allegations
45:45
Accusations of Data Suppression by Pharma
46:17
Claiming Pharmaceutical Influence Over Science
46:48
Rebuttal of FDA and CDC Authority
47:19
Discussion of European Regulatory Control
47:50
Measles Cases in Texas and Public Health Messaging
48:20
Linking Low Vaccination to Measles Outbreaks
49:21
Supplement Sales Accusations and Counterarguments
49:58
Discussion of Nattokinase Supplement Claims
50:28
Debate Over Unregulated Supplements and Personal Injury
51:28
Comparison of Vaccine Safety to Supplement Risks
53:03
Discussion of Net Worth and Professional Reputation
53:35
Questioning Record Review Credibility
53:51
Final Remarks on Measles Deaths in Texas
54:05
Claim of Determining Cause of Death
54:36
Defending Measles as Primary Cause
55:10
Evidence of Measles in Lungs and Secondary Infections
56:14
Impact of Vaccination on Secondary Bacterial Outcomes
57:47
Critique of Mismanagement and Wrong Doctors
58:48
Reference to Samoa Measles Outbreak and RFK
1:00:21
Doctors Losing Licenses Amid Vaccine Debate
1:00:52
Measles Vaccine Claims and Island Outbreaks
1:01:23
Samoa Measles Outbreak and Vaccination Rate Collapse
1:02:24
Measles Reservoirs, Travel, and Vaccine Coverage
1:02:54
Immunity Erosion Due to Misinformation Campaigns
1:03:25
Ranking of Antivax Influencers and Removal Strategies
1:03:56
All‑Cause Mortality Study Following Measles Vaccine Rollout
1:04:28
Timing of Vaccine Introduction and Immune Amnesia Evidence
1:05:30
Memory B/T Cells, Immune Amnesia, and Disinformation Tactics
1:08:06
Shadowy Network Claims vs. Tobacco Marketing History
1:08:36
Scientific Consensus on Smoking Harm Over Centuries
1:09:07
Pharma’s Regulatory Oversight and Independent Research
1:09:39
Public Perception of Pharma Ownership Claims
1:10:43
MMR Vaccine Effectiveness and Misinformation
1:11:13
RFK Jr. Funding of mRNA Vaccine Research and HIV Vaccine Claims
1:13:17
COVID‑19 Vaccine Data Transparency and Access Challenges
1:13:48
Critique of Unverified COVID‑19 Vaccine Death Claims
1:14:20
Data Access Procedures for Large‑Scale Health Studies
1:15:22
Accusations of Incompetence
1:15:53
Questioning Data Availability
1:16:24
Randomization Claims
1:16:55
Preferential Recommendations
1:18:28
Group Comparability
1:18:59
Control for Confounders
1:21:32
Personal Treatment Story
1:22:04
Anecdotal Evidence Caveat
1:22:34
Career End After Senate Hearing
1:23:06
Accusations of Losing Medical License
1:23:37
Claims of Drug Efficacy Without Evidence
1:24:08
Media Response and Public Perception
1:24:39
Comparison to Other Repurposed Drugs
1:25:09
Presentation of Clinical Trial Data
1:26:13
Accusations Against Simone Gold and Others
1:27:14
Financial Motives and Legal Issues of Critics
1:27:46
Defense of Scientific Methodology
1:28:10
Critique of Public Figures’ Claims and Data Suppression
1:29:18
Argument for Responsible Communication of Results
1:30:20
Accusation of Misleading Language About Drug Efficacy
1:30:51
Rebuttal and Clarification of Terminology Used in Senate Hearing
1:31:21
Examination of Protocol Publication Prior to Clinical Results
1:31:53
Discussion of Career Shift from Medicine to Online Promotion
1:32:23
Overview of Cheap Generic Drugs Repurposed for COVID Treatment
1:32:54
Critique of Pharmaceutical Suppression Narrative
1:33:26
Presentation of Global Randomized Trials Showing No Benefit
1:34:59
Analysis of Trial Design Variations and Their Outcomes
1:35:30
Critique of Meta‑Analysis Methodology and Data Selection
1:36:01
Discussion of Global Trial Consensus on Lack of Efficacy
1:37:34
Host Accuses Antivax Doctors of Concealing Findings
1:38:05
Host Labels Opponents as “Shills” and Criticizes Their Credibility
1:38:35
Host Describes Near-Physical Confrontation with Attendee
1:39:38
Host Explains Emotional State During Debate
1:40:08
Host Reflects on Avoiding Physical Violence
1:40:48
Host Critiques Antivax Debate Tactics Compared to Previous Event
1:41:12
Host Discusses Audience Composition and Future Debate Locations
1:41:42
Host Announces Plans to Expose Antivax Figures in Detail
48m⏭ 1
1h 20m
1h 40m⏭ 3
1h 22m
1h 50m⏭ 3
1h 0m⏭ 1
31m⏭ 1
4h 6m⏭ 2
1h 16m⏭ 4
2h 15m⏭ 2
1h 1m
1h 28m⏭ 2